Literature DB >> 6105309

Timing of indomethacin therapy in persistent ductus.

J Firth, D Pickering.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6105309     DOI： 10.1016/s0140-6736(80)90023-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity.

Authors:  J M Rennie; R W Cooke
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

2.  Early treatment of patent ductus arteriosus in premature infants with severe respiratory distress syndrome.

Authors:  G Pongiglione; M Marasini; G Silvestri; P Tuo; D Ribaldone; A Bertolini; L Garello-Cantoni
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

3.  Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.

Authors:  Justin J Elhoff; Myla Ebeling; Thomas C Hulsey; Andrew M Atz
Journal:  Congenit Heart Dis       Date:  2015-07-20       Impact factor: 2.007

4.  Intravenous indomethacin for patent ductus arteriosus.

Authors:  I J Smith; I Goss; P J Congdon
Journal:  Arch Dis Child       Date:  1984-06       Impact factor: 3.791

Review 5.  Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider.

Authors:  Carl H Backes; Kevin D Hill; Elaine L Shelton; Jonathan L Slaughter; Tamorah R Lewis; Dany E Weisz; May Ling Mah; Shazia Bhombal; Charles V Smith; Patrick J McNamara; William E Benitz; Vidu Garg
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.